SPI1 Antibody (monoclonal) (M02)
Mouse monoclonal antibody raised against a partial recombinant SPI1.
- 产品详情
- 实验流程
- 背景知识
Application
| WB, IF, E |
|---|---|
| Primary Accession | P17947 |
| Other Accession | NM_003120 |
| Reactivity | Human, Mouse |
| Host | mouse |
| Clonality | monoclonal |
| Isotype | IgG1 Kappa |
| Clone Names | 2G1 |
| Calculated MW | 31083 Da |
| Gene ID | 6688 |
|---|---|
| Other Names | Transcription factor PU1, 31 kDa-transforming protein, SPI1 |
| Target/Specificity | SPI1 (NP_003111, 1 a.a. ~ 120 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
| Dilution | WB~~1:500~1000 IF~~1:50~200 E~~N/A |
| Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
| Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Precautions | SPI1 Antibody (monoclonal) (M02) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes an ETS-domain transcription factor that activates gene expression during myeloid and B-lymphoid cell development. The nuclear protein binds to a purine-rich sequence known as the PU-box found near the promoters of target genes, and regulates their expression in coordination with other transcription factors and cofactors. The protein can also regulate alternative splicing of target genes. Multiple transcript variants encoding different isoforms have been found for this gene.
REFERENCES
PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element. Bonadies N, et al. Oncogene, 2010 Feb 18. PMID 19966852.Heterozygous deletion of the PU.1 locus in human AML. Bonadies N, et al. Blood, 2010 Jan 14. PMID 19890096.PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells. Desai S, et al. J Immunol, 2009 Nov 1. PMID 19828640.PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation. Burda P, et al. Mol Cancer Res, 2009 Oct. PMID 19825991.PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL. Ueno S, et al. Oncogene, 2009 Nov 19. PMID 19749795.
终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.
















癌症的基本特征包括细胞增殖、血管生成、迁移、凋亡逃避机制和细胞永生等。找到癌症发生过程中这些通路的关键标记物和对应的抗体用于检测至关重要。
为您推荐一个泛素化位点预测神器——泛素化分析工具,可以为您的蛋白的泛素化位点作出预测和评分。
细胞自噬受体图形绘图工具为你的蛋白的细胞受体结合位点作出预测和评分,识别结合到自噬通路中的蛋白是非常重要的,便于让我们理解自噬在正常生理、病理过程中的作用,如发育、细胞分化、神经退化性疾病、压力条件下、感染和癌症。